-
Journal of Asthma and Allergy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
The effect of Helicobacter pylori on asthma and allergy
Review
(3464) Views (797) Full article downloads
Authors: Amedeo Amedei, Gaia Codolo, Gianfranco Del Prete, et al
Published Date September 2010
Volume 2010:3 Pages 139 - 147
DOI: http://dx.doi.org/10.2147/JAA.S8971
Amedeo Amedei1, Gaia Codolo2, Gianfranco Del Prete1, Marina de Bernard2, Mario M D’Elios11Policlinico AOU Careggi, Department Internal Medicine, University of Florence, Italy; 2Venetian Institute of Molecular Medicine, University of Padua, Italy
Abstract: Current evidence indicates an inverse association between Helicobacter pylori and asthma and allergy. H. pylori is a Gram-negative bacterium which represents the major cause of peptic ulcer and gastric cancer, and preferentially elicits a T helper (Th)-1 response. Many H. pylori factors, such as the neutrophil-activating factor of H. pylori (HP-NAP), are able to drive Th-1 polarization and to display a powerful inhibition of allergic Th-2 response. This article proposes an overview of the actual knowledge about the effects of H. pylori on asthma and allergy. Special attention has been drawn to HP-NAP as a potential novel strategy for the prevention and treatment of asthma and atopy.
Keywords: Helicobacter pylori neutrophil-activating factor, protein, Th-1/Th-2, Treg, asthma
Readers of this article also read:
Viral asthma: implications for clinical practice
The impact of food allergy on asthma
Immunological and genetic aspects of asthma and allergy
The impact of asthma on the gastrointestinal tract (GIT)
Current recommendations for the treatment of mild asthma
New therapies and management strategies in the treatment of asthma: patient-focused developments
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
Update on optimal use of omalizumab in management of asthma
Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




